3 recruiting, 1 not yet recruiting. 3 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 3 |
| Not applicable | 1 | Not yet recruiting 1 |
Follow Consolidation Therapy: new trials by email Literature Review of Consolidation Therapy trials Research Report on Consolidation Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Total Neoadjuvant Therapy With Additional Consolidation Chemotherapy Followed by Local Excision Versus Total Neoadjuvant Therapy Followed by Local Excision at Stage I Rectal Cancer TNT with additional consolidation chemotherapy followed by local excision, TNT followed by local excision - Organ Preservation, Rectal Cancer Stage I | Not applicable | Not yet recruiting | Seoul National University Hospital | 292 | 2026-06-01 | 2026-05-04 |
| VA Consolidation in Intermediate-Risk AML Venetoclax and Azacitidine, Cytarabine ± Anthracycline - Acute Myeloid Leukemia, Intermediate Risk Acute Myeloid Leukemia | Phase 2 | Recruiting | The First Affiliated Hospital of Soochow University | 226 | 2026-06-01 | 2026-08-06 |
| Venetoclax Combined With Azacitidine for Consolidation Therapy in AML Ara-C Group, VEN/AZA condsolidation - Acute Myeloid Leukemia, Consolidation Therapy | Phase 2 | Recruiting | The First Affiliated Hospital of Soochow University | 216 | 2026-02-01 | 2026-08-06 |
| Combination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advanced Non-Small Cell Lung Cancer Surufatinib, Tislelizumab, Concurrent Chemotherapy - Surufatinib, Tislelizumab | Phase 2 | Recruiting | Sun Yat-sen University | 80 | 2025-07-20 | 2025-07-25 |
Leukemia, Myeloid, Acute (2) · Carcinoma, Non-Small-Cell Lung (1) · Rectal Neoplasms (1)
Neoplasms (4) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Leukemia (2) · Leukemia, Myeloid (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Colorectal Neoplasms (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Intestinal Diseases (1)
Azacitidine (1) · Radiotherapy (1) · Trinitrotoluene (1) · surufatinib (1) · tislelizumab (1) · venetoclax (1)
The First Affiliated Hospital of Soochow University (2) · Seoul National University Hospital (1) · Sun Yat-sen University (1)
China (3) · South Korea (1)